Evidence map›Paper›PMID 40224160›Full record

ArticleStrategies in trauma and limb reconstruction

Fitbone vs Precice: Is There a Difference in Regenerate Healing?

Peter Calder, Alastair Robertson, Elizabeth K Tissingh, Jonathan Wright, David Goodier

Abstract read
In one paragraph

Article in Strategies in trauma and limb reconstruction. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Peter CalderDepartment of Trauma and Orthopaedics, The Royal National Orthopaedic Hospital, Stanmore, London, England, United Kingdom.
Alastair RobertsonDepartment of Limb Reconstruction, The Royal National Orthopaedic Hospital, Stanmore, London, England, United Kingdom.
Elizabeth K TissinghDepartment of Limb Reconstruction, The Royal National Orthopaedic Hospital, Stanmore, London, England, United Kingdom.
Jonathan WrightDepartment of Paediatric and Limb Reconstruction Unit, The Royal National Orthopaedic Hospital, Stanmore, London, England, United Kingdom.ORCID https://orcid.org/0000-0001-6055-648X
David GoodierDepartment of Paediatric and Limb Reconstruction Unit, The Royal National Orthopaedic Hospital, Stanmore, London, England, United Kingdom.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The use of intramedullary lengthening nails (ILN) is now an accepted limb reconstruction technique. The most popular motorised systems enable optimal conditions for lengthening, namely stability, sub-millimetre accurate lengthening or retraction and an avoidance of common complications associated with external fixators, such as pin site infections, muscle tethering and regenerate deformity or fracture. The fitbone stainless steel implant utilises an electrical current transmitted by a subcutaneous antenna to drive the motor. The precise intramedullary system, made of titanium, is lengthened by a rotating magnet driven by an electronic remote controller. To prevent nail breakage or deformity, protected partial weight-bearing is initially advised and weight-bearing permitted when sufficient regenerate has formed in the distraction gap. Purpose: The aim of our study was to evaluate and compare the regenerate formation following lengthening using two different motorised ILN. Methods: A retrospective review identified 13 patients (13 nails) who underwent femoral lengthening using the fitbone and 14 patients (16 nails) lengthened with the precise. Patients were matched for age, sex, aetiology and length achieved.Regenerate analysis was undertaken using the pixel ratio value (PVR), calculated on the radiographs when at the desired length, followed at 4, 8, and 12 weeks. The mean of the two highest ratio values were also assessed, as an indicator that full weight-bearing would be permitted. Complications were recorded in relation to bone, soft tissues and implant. Results: Seven males and 6 females underwent 10 antegrade and 3 retrograde fitbone lengthening. Nine male and 5 female underwent 14 antegrade and one retrograde precise lengthening. The mean age at surgery was 36 years in both groups. Mean length in the fitbone group was 41.7, and 46.8 mm in the precise group. All except one fitbone patient reached the desired length (6 mm short). The regenerate fully consolidated in all patients.There was no statistical difference between the PVR measurements of the cortices at any time interval. There was no difference seen in the time for full weight-bearing or a difference seen in the mean PVR measured at this particular time. There were complications seen in the fitbone group including bolt migration, premature consolidation, and soft tissue irritation from the antenna requiring early surgical removal. There were no complications recorded in the precise group. Discussion: This study has demonstrated no difference between the regenerate formation following femoral lengthening, with either the fitbone or precise ILN. All patients had full bone consolidation and there was no difference seen in time to full weight-bearing following completion of lengthening. The rate of complications seen in the fitbone group may be explained by the learning curve of a new implant.There are several limitations including a retrospective review of a small cohort of patients. However, we conclude that both implants successfully lengthen and form excellent regenerate bone. We would recommend that the choice of implant should not be determined by the potential regenerate formation. How to cite this article: Calder P, Robertson A, Tissingh EK,

Indexed as

Fitbone nailIntramedullary lengthening nailPrecise nailRegenerate healing

Identifiers

PMID40224160
PMCPMC11982906

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.